ProPhase Labs Inc. filed for Chapter 11 bankruptcy for its three COVID-19 testing lab units to recover tens of millions owed by insurance companies. Attorneys estimate potential cash collections of $50 million for the company. Shareholders approved a crypto treasury strategy to enhance value. PRPH stock fell 1% to $0.4453 on Sep. 23.

Read more at Yahoo Finance: Biotech firm files Chapter 11 bankruptcy for 3 labs, explores crypto plan